Gilder Gagnon Howe & CO LLC Bio N Tech Se Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 275,831 shares of BNTX stock, worth $27.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

275,831

Previous 277,298 0.53%

Holding current value

$27.5 Million

Previous $22.3 Million 47.02%

% of portfolio

0.42%

Previous 0.29%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $114,954 - $182,876	-1,467 Reduced 0.53%	275,831 $32.8 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $204,918 - $262,318	2,550 Added 0.93%	277,298 $22.3 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $7.56 Million - $9.55 Million	-84,960 Reduced 23.62%	274,748 $25.3 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $4.24 Million - $5.26 Million	-46,685 Reduced 11.49%	359,708 $38 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $5.5 Million - $6.99 Million	-55,885 Reduced 12.09%	406,393 $44.2 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $658,768 - $832,676	6,422 Added 1.41%	462,278 $49.9 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $314,269 - $394,009	-2,564 Reduced 0.56%	455,856 $56.8 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $4.79 Million - $7.53 Million	40,478 Added 9.69%	458,420 $68.9 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $18.6 Million - $26.7 Million	145,658 Added 53.49%	417,942 $56.4 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $3.43 Million - $5.18 Million	-27,800 Reduced 9.26%	272,284 $40.6 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $7.19 Million - $13.2 Million	-56,990 Reduced 15.96%	300,084 $51.2 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $66.3 Million - $111 Million	305,931 Added 598.19%	357,074 $92.1 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $2.92 Million - $6.34 Million	14,178 Added 38.36%	51,143 $14 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $4.19 Million - $8.93 Million	36,965 New	36,965 $8.28 Million

Others Institutions Holding BNTX

# of Institutions

358

Shares Held

38.4M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Bio N Tech Se Transaction History